search
Back to results

Reducing Post-traumatic Stress Disorder After ICU Discharge With the IPREA3 Program (PTSD-REA)

Primary Purpose

Critical Illness

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Administration of the IPREA3 questionnaire
Immediate feedback through electronic reminder messages
Targeted interventions in each ICU to reduce discomforts
6 months follow-up to assess the prevalence of PTSD symptoms
1 year follow-up to assess psychiatric morbidity
Sponsored by
Centre Hospitalier of Chartres
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Critical Illness focused on measuring Critical care, Post-traumatic stress disorder, Discomfort, Tailored program, Patient-reported outcome, ICU, COVID-19

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients who survived an ICU stay of at least 3 calendar days
  • Affiliation to a social security scheme
  • First stay in ICU during current short-term hospitalization
  • Patient's oral consent to participate in the PTSD-REA_COVID cohort

Exclusion Criteria:

  • Deceased during the ICU stay
  • Minors
  • Under trusteeship
  • Without affiliation to a social security scheme
  • Transferred to another ICU
  • Already hospitalized in ICU during the current short stay
  • Already included in the study
  • Limitation and cessation of active treatment
  • Advance healthcare directive indicating the refusal of ICU stay
  • Irreversible state like diminished cognitive capacity based on the investigator's opinion or not understanding French sufficiently to be questioned (language barrier)
  • Subject not consenting to participate in the study

Sites / Locations

  • CHU Angers
  • CHU d'Angers
  • CH d'Auxerre
  • CH de Blois
  • Clinique Convert
  • CH Bourges
  • Hôpital Louis Pasteur
  • CHU de Dijon
  • CH de Douai
  • CH Emile Roux
  • CH de Lens
  • Hôpital Edouard Herriot
  • Hôpital Européen de Marseille
  • Hôpital Nord_APHM
  • Hôpital Nord_APHM
  • CH de l'Agglomération Montargoise
  • GHR Mulhouse Sud-Alsace
  • CH de Mâcon
  • Clinique Ambroise Paré
  • Hôpital Pasteur 2_CHU de Nice
  • Hôpital Saint-Louis_APHP
  • Gaston Cordier_GH La Pitié-Salpêtrière-Charles Foix_APHP
  • GH La Pitié-Salpêtrière-Charles Foix_APHP
  • Husson Mourier_GH La Pitié-Salpêtrière-Charles Foix_APHP
  • CHU de Poitiers
  • Hôpital privé Claude Galien
  • CH Victor Provo
  • NCT+ - St Gatien
  • Nouvel Hôpital Civil_CHU de Strasbourg
  • Hôpital de Hautepierre_CHU de Strasbourg
  • Hôpital Sainte Musse
  • CHRU de Tours
  • CH de Troyes

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Other

Active Comparator

Other

Arm Label

IPREA3 program

Intermediate group

Standard care

PTSD-REA_COVID cohort

Arm Description

Application of the IPREA 3 program (multicomponent intervention to reduce perceived discomforts in critically ill patients) for at least 5 months

Application of the IPREA 3 program (multicomponent intervention to reduce perceived discomforts in critically ill patients) for less than 5 months

Standard care

ICU admission between March 1, 2020 and April 30, 2020.

Outcomes

Primary Outcome Measures

Presence of posttraumatic stress disorder (PTSD) symptoms at one year after ICU discharge and 6 months ( PTSD-REA_COVID cohort)
PTSD symptoms at one year will be assessed from the PCL-5 which is a 20-item self-report measure that assesses the 20 DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) symptoms of PTSD. Each item is rated from 0 "Not at all" to 4 "Extremely". A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items. A provisional PTSD diagnosis can be made by treating each item rated as 2 = "Moderately" or higher as a symptom endorsed, then following the DSM-5 diagnostic rule which requires at least: 1 B item (questions 1-5), 1 C item (questions 6-7), 2 D items (questions 8-14), 2 E items (questions 15-20).

Secondary Outcome Measures

ICU stay's duration
Number of days with mechanical ventilation
Overall score of discomfort assessed from the IPREA3 questionnaire
The duration of hospital stay after ICU discharge
Intrusion Symptom Category B assessed from the PCL-5 (Posttraumatic Stress Disorder Checklist ) (Items 1-5)
Recurrent or involuntary distressing dreams, memories, thoughts, or feelings related to the traumatic event(s)
Persistent Avoidance Category C assessed from the PCL-5 (Items 6-7)
Avoidance or efforts to avoid internal or external reminders of the traumatic event(s)
Negative Alterations in Cognitions and Mood Category D assessed from PCL 5 (Items 8-14)
Persistent and exaggerated negative beliefs about oneself, the world, others, negative mood states, inability to experience positive emotions
Alterations in arousal and reactivity Category E assessed from the PCL-5 (Items 15-20)
Marked increase in arousal or reactivity such as irritability, hypervigilance, exaggerated startle response, sleep or concentration problems exaggerated startle response
Score of the sub-scale A of the questionnaire HAD-S (Hospital and Anxiety Depression Scale)
Allowing to estimate the presence of anxious symptoms. The scale HAD contains 14 items rated from 0 to 3. The score of Anxiety ( total A) is obtained by summing items 1-3-5-7-9-11-13 and the depressive dimension (total D) is obtained by summing items 2-4-6-8-10-12-14. The maximal note for each of them is 21. 8 points is a minimum threshold for determining whether the anxiety is clinically meaningful
Score of the sub-scale D of the questionnaire HAD-S ( Hospital and Anxiety Depression Scale)
Allowing to estimate the presence of anxious symptoms. The scale HAD contains 14 items rated from 0 to 3. The score of Anxiety ( total A) is obtained by summing items 1-3-5-7-9-11-13 and the depressive dimension (total D) is obtained by summing items 2-4-6-8-10-12-14. The maximal note for each of them is 21. 8 points is a minimum threshold for determining whether Depression is clinically meaningful
Score obtained from The World Health Organization Quality of Life (WHOQOL-BREF)
The WHOQOL-BREF measure the following broad domains: physical health, psychological health, social relationships, and environment. Each item is rated from 0 to 5. The score of each domain is obtained by summing items then standardized on a scale of 0 (worst quality of life related to health in the dimension explored) to 100 (better quality of liferelated to health in the dimension explored).
Number of emergency stays
Since ICU discharge
Number of hospitalization
Since ICU discharge
Number of psychiatric or psychological consultation
Since ICU discharge
The place of leaving after ICU stay
Evaluated in population of patients living at home before the ICU stay.
Presence of professional activity
Evaluated in population of patients with a professional activity before ICU stay

Full Information

First Posted
June 11, 2019
Last Updated
March 8, 2022
Sponsor
Centre Hospitalier of Chartres
search

1. Study Identification

Unique Protocol Identification Number
NCT03991611
Brief Title
Reducing Post-traumatic Stress Disorder After ICU Discharge With the IPREA3 Program
Acronym
PTSD-REA
Official Title
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2019 (Actual)
Primary Completion Date
July 31, 2022 (Anticipated)
Study Completion Date
January 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier of Chartres

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Reducing discomfort in the intensive care unit (ICU) should be beneficial to longterm outcomes. This study assesses whether a tailored multicomponent program for discomfort reduction may be effective in reducing post-traumatic stress disorder (PTSD) symptoms at 1-year in general ICU survivors. The psychiatric morbidity may be increased by the COVID-19 epidemic and its consequences on the healthcare system (patient care, reorganization of French ICUs). The main objective of PTSD-REA_COVID cohort is to assess this psychiatric morbidity 6 months after an ICU stay during the epidemic period.
Detailed Description
After carrying out the cluster-randomized controlled IPREA3 study demonstrating that a tailored multicomponent program based on assessment of self-perceived discomfort, feedback to the healthcare teams, and tailored site-targeted measures was effective to decrease self-perceived overall discomfort, we performed the 1-year follow-up of ICUs survivors included in the IPREA3 study to assess psychiatric morbidity at 1 year. Our tailored multicomponent program was also associated with less PTSD at 1 year after ICU discharge. Based on this positive long-term result, this study confirms the need to implement a new strategy for reducing discomfort in the ICU based on such programs. PTSD-REA is a stepped wedge cluster randomized trial involving 18 ICUs. The exposure will be the implementation of a tailored multicomponent program consisting of assessment of ICU-related self-perceived discomforts, immediate and monthly feedback to the healthcare team, and site-specific tailored interventions. The eligible patients will be exposed vs. unexposed general adult ICU survivors. The prevalence of substantial posttraumatic stress disorder (PTSD) symptoms at 1 year will be assessed by using diagnostic criteria adapted to the new definition of PTSD according to DSM-5. The current context of the COVID-19 pandemic has considerably disrupted the ICUs organizations as well as the patients care which may lead to increased psychiatric morbidity. In this context, it seems necessary to assess this phenomenon in order to anticipate the consequences on patients but also on the healthcare system. The objectives of the PTSD-REA_COVID cohort are to assess the prevalence of PTSD symptoms, 6 months after ICU stay during COVID-19 epidemic and to compare the psychiatric morbidity at 1 year after an ICU stay during epidemic period and non epidmic period.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
Keywords
Critical care, Post-traumatic stress disorder, Discomfort, Tailored program, Patient-reported outcome, ICU, COVID-19

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Stepped wedge cluster randomized trial
Masking
Participant
Allocation
Randomized
Enrollment
3312 (Actual)

8. Arms, Groups, and Interventions

Arm Title
IPREA3 program
Arm Type
Experimental
Arm Description
Application of the IPREA 3 program (multicomponent intervention to reduce perceived discomforts in critically ill patients) for at least 5 months
Arm Title
Intermediate group
Arm Type
Other
Arm Description
Application of the IPREA 3 program (multicomponent intervention to reduce perceived discomforts in critically ill patients) for less than 5 months
Arm Title
Standard care
Arm Type
Active Comparator
Arm Description
Standard care
Arm Title
PTSD-REA_COVID cohort
Arm Type
Other
Arm Description
ICU admission between March 1, 2020 and April 30, 2020.
Intervention Type
Other
Intervention Name(s)
Administration of the IPREA3 questionnaire
Intervention Description
On the day of the ICU discharge, the bedside nurse administers to the patient the 18-item IPREA questionnaire i.e the nurse asks the patient to rate from 0 to 10 the severity of each discomfort source contained in the IPREA3 questionnaire experienced during the entire stay in the ICU
Intervention Type
Other
Intervention Name(s)
Immediate feedback through electronic reminder messages
Intervention Description
After the nurse had administered the questionnaire, warning messages are displayed on the screen corresponding to the key points to prevent the three discomforts reported with the highest scores
Intervention Type
Other
Intervention Name(s)
Targeted interventions in each ICU to reduce discomforts
Intervention Description
These targeted interventions are implemented through the coordination of two local champions. The central coordination IPREA3 team sends each month to the local champions monthly and cumulative discomfort scores of their unit (overall score of discomfort and scores for each item) and their ranking relative to other units assigned to the interventional arm i.e applying the IPREA3 program. The local champions organize monthly meetings with the unit staff to present the results in terms of perceived discomforts measured by the IPREA questionnaire, identify main discomfort sources and actions to be conducted to reduce the discomforts reported with the highest scores in the unit and those that are most easily preventable, and assess the efficacy of already applied measures.
Intervention Type
Other
Intervention Name(s)
6 months follow-up to assess the prevalence of PTSD symptoms
Intervention Description
Psychologist will collect the PCL-5, HAD-S, WHOQOL-BREF, LEC-5 items during the telephone follow-up, 6 months after ICU discharge .
Intervention Type
Other
Intervention Name(s)
1 year follow-up to assess psychiatric morbidity
Intervention Description
Psychologist will collect the PCL-5, HAD-S, WHOQOL-BREF, LEC-5 and CTQ items during the telephone follow-up, 1 year after ICU discharge .
Primary Outcome Measure Information:
Title
Presence of posttraumatic stress disorder (PTSD) symptoms at one year after ICU discharge and 6 months ( PTSD-REA_COVID cohort)
Description
PTSD symptoms at one year will be assessed from the PCL-5 which is a 20-item self-report measure that assesses the 20 DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) symptoms of PTSD. Each item is rated from 0 "Not at all" to 4 "Extremely". A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items. A provisional PTSD diagnosis can be made by treating each item rated as 2 = "Moderately" or higher as a symptom endorsed, then following the DSM-5 diagnostic rule which requires at least: 1 B item (questions 1-5), 1 C item (questions 6-7), 2 D items (questions 8-14), 2 E items (questions 15-20).
Time Frame
One year after ICU discharge
Secondary Outcome Measure Information:
Title
ICU stay's duration
Time Frame
The day of ICU discharge
Title
Number of days with mechanical ventilation
Time Frame
The day of ICU discharge
Title
Overall score of discomfort assessed from the IPREA3 questionnaire
Time Frame
The day of ICU discharge
Title
The duration of hospital stay after ICU discharge
Time Frame
6 months ( PTSD-REA_COVID cohort) or 1 year after ICU discharge and
Title
Intrusion Symptom Category B assessed from the PCL-5 (Posttraumatic Stress Disorder Checklist ) (Items 1-5)
Description
Recurrent or involuntary distressing dreams, memories, thoughts, or feelings related to the traumatic event(s)
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Persistent Avoidance Category C assessed from the PCL-5 (Items 6-7)
Description
Avoidance or efforts to avoid internal or external reminders of the traumatic event(s)
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Negative Alterations in Cognitions and Mood Category D assessed from PCL 5 (Items 8-14)
Description
Persistent and exaggerated negative beliefs about oneself, the world, others, negative mood states, inability to experience positive emotions
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Alterations in arousal and reactivity Category E assessed from the PCL-5 (Items 15-20)
Description
Marked increase in arousal or reactivity such as irritability, hypervigilance, exaggerated startle response, sleep or concentration problems exaggerated startle response
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Score of the sub-scale A of the questionnaire HAD-S (Hospital and Anxiety Depression Scale)
Description
Allowing to estimate the presence of anxious symptoms. The scale HAD contains 14 items rated from 0 to 3. The score of Anxiety ( total A) is obtained by summing items 1-3-5-7-9-11-13 and the depressive dimension (total D) is obtained by summing items 2-4-6-8-10-12-14. The maximal note for each of them is 21. 8 points is a minimum threshold for determining whether the anxiety is clinically meaningful
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Score of the sub-scale D of the questionnaire HAD-S ( Hospital and Anxiety Depression Scale)
Description
Allowing to estimate the presence of anxious symptoms. The scale HAD contains 14 items rated from 0 to 3. The score of Anxiety ( total A) is obtained by summing items 1-3-5-7-9-11-13 and the depressive dimension (total D) is obtained by summing items 2-4-6-8-10-12-14. The maximal note for each of them is 21. 8 points is a minimum threshold for determining whether Depression is clinically meaningful
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Score obtained from The World Health Organization Quality of Life (WHOQOL-BREF)
Description
The WHOQOL-BREF measure the following broad domains: physical health, psychological health, social relationships, and environment. Each item is rated from 0 to 5. The score of each domain is obtained by summing items then standardized on a scale of 0 (worst quality of life related to health in the dimension explored) to 100 (better quality of liferelated to health in the dimension explored).
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Number of emergency stays
Description
Since ICU discharge
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Number of hospitalization
Description
Since ICU discharge
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Number of psychiatric or psychological consultation
Description
Since ICU discharge
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
The place of leaving after ICU stay
Description
Evaluated in population of patients living at home before the ICU stay.
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge
Title
Presence of professional activity
Description
Evaluated in population of patients with a professional activity before ICU stay
Time Frame
6 months ( PTSD-REA_COVID cohort) and1 year after ICU discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients who survived an ICU stay of at least 3 calendar days Affiliation to a social security scheme First stay in ICU during current short-term hospitalization Patient's oral consent to participate in the PTSD-REA_COVID cohort Exclusion Criteria: Deceased during the ICU stay Minors Under trusteeship Without affiliation to a social security scheme Transferred to another ICU Already hospitalized in ICU during the current short stay Already included in the study Limitation and cessation of active treatment Advance healthcare directive indicating the refusal of ICU stay Irreversible state like diminished cognitive capacity based on the investigator's opinion or not understanding French sufficiently to be questioned (language barrier) Subject not consenting to participate in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre KALFON, MD PhD
Organizational Affiliation
CH Chartres
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Angers
City
Angers
ZIP/Postal Code
49100
Country
France
Facility Name
CHU d'Angers
City
Angers
ZIP/Postal Code
49933
Country
France
Facility Name
CH d'Auxerre
City
Auxerre
ZIP/Postal Code
89000
Country
France
Facility Name
CH de Blois
City
Blois
ZIP/Postal Code
41016
Country
France
Facility Name
Clinique Convert
City
Bourg-en-Bresse
ZIP/Postal Code
01000
Country
France
Facility Name
CH Bourges
City
Bourges
ZIP/Postal Code
18033
Country
France
Facility Name
Hôpital Louis Pasteur
City
Chartres
ZIP/Postal Code
28000
Country
France
Facility Name
CHU de Dijon
City
Dijon
ZIP/Postal Code
21079
Country
France
Facility Name
CH de Douai
City
Douai
ZIP/Postal Code
59507
Country
France
Facility Name
CH Emile Roux
City
Le Puy-en-Velay
ZIP/Postal Code
43000
Country
France
Facility Name
CH de Lens
City
Lens
ZIP/Postal Code
62300
Country
France
Facility Name
Hôpital Edouard Herriot
City
Lyon
ZIP/Postal Code
69437
Country
France
Facility Name
Hôpital Européen de Marseille
City
Marseille
ZIP/Postal Code
13003
Country
France
Facility Name
Hôpital Nord_APHM
City
Marseille
ZIP/Postal Code
13015
Country
France
Facility Name
Hôpital Nord_APHM
City
Marseille
ZIP/Postal Code
13326
Country
France
Facility Name
CH de l'Agglomération Montargoise
City
Montargis
ZIP/Postal Code
45207
Country
France
Facility Name
GHR Mulhouse Sud-Alsace
City
Mulhouse
ZIP/Postal Code
68100
Country
France
Facility Name
CH de Mâcon
City
Mâcon
ZIP/Postal Code
71000
Country
France
Facility Name
Clinique Ambroise Paré
City
Neuilly-sur-Seine
ZIP/Postal Code
92200
Country
France
Facility Name
Hôpital Pasteur 2_CHU de Nice
City
Nice
ZIP/Postal Code
06006
Country
France
Facility Name
Hôpital Saint-Louis_APHP
City
Paris
ZIP/Postal Code
75010
Country
France
Facility Name
Gaston Cordier_GH La Pitié-Salpêtrière-Charles Foix_APHP
City
Paris
ZIP/Postal Code
75013
Country
France
Facility Name
GH La Pitié-Salpêtrière-Charles Foix_APHP
City
Paris
ZIP/Postal Code
75013
Country
France
Facility Name
Husson Mourier_GH La Pitié-Salpêtrière-Charles Foix_APHP
City
Paris
ZIP/Postal Code
75013
Country
France
Facility Name
CHU de Poitiers
City
Poitiers
ZIP/Postal Code
86021
Country
France
Facility Name
Hôpital privé Claude Galien
City
Quincy-sous-Sénart
ZIP/Postal Code
91480
Country
France
Facility Name
CH Victor Provo
City
Roubaix
ZIP/Postal Code
59100
Country
France
Facility Name
NCT+ - St Gatien
City
Saint-Cyr-sur-Loire
ZIP/Postal Code
37540
Country
France
Facility Name
Nouvel Hôpital Civil_CHU de Strasbourg
City
Strasbourg
ZIP/Postal Code
67091
Country
France
Facility Name
Hôpital de Hautepierre_CHU de Strasbourg
City
Strasbourg
ZIP/Postal Code
67098
Country
France
Facility Name
Hôpital Sainte Musse
City
Toulon
ZIP/Postal Code
83000
Country
France
Facility Name
CHRU de Tours
City
Tours
ZIP/Postal Code
37044
Country
France
Facility Name
CH de Troyes
City
Troyes
ZIP/Postal Code
1000
Country
France

12. IPD Sharing Statement

Plan to Share IPD
Yes
Citations:
PubMed Identifier
23084614
Citation
Jones C. Surviving the intensive care: residual physical, cognitive, and emotional dysfunction. Thorac Surg Clin. 2012 Nov;22(4):509-16. doi: 10.1016/j.thorsurg.2012.07.003. Epub 2012 Aug 25.
Results Reference
result
PubMed Identifier
14530751
Citation
Jones C, Skirrow P, Griffiths RD, Humphris GH, Ingleby S, Eddleston J, Waldmann C, Gager M. Rehabilitation after critical illness: a randomized, controlled trial. Crit Care Med. 2003 Oct;31(10):2456-61. doi: 10.1097/01.CCM.0000089938.56725.33.
Results Reference
result
PubMed Identifier
23247200
Citation
Pacella ML, Hruska B, Delahanty DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord. 2013 Jan;27(1):33-46. doi: 10.1016/j.janxdis.2012.08.004. Epub 2012 Sep 13.
Results Reference
result
PubMed Identifier
24088092
Citation
Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372.
Results Reference
result
PubMed Identifier
25083985
Citation
Davydow DS, Hough CL, Zatzick D, Katon WJ. Psychiatric symptoms and acute care service utilization over the course of the year following medical-surgical ICU admission: a longitudinal investigation*. Crit Care Med. 2014 Dec;42(12):2473-81. doi: 10.1097/CCM.0000000000000527.
Results Reference
result
PubMed Identifier
16783553
Citation
Dowdy DW, Eid MP, Dennison CR, Mendez-Tellez PA, Herridge MS, Guallar E, Pronovost PJ, Needham DM. Quality of life after acute respiratory distress syndrome: a meta-analysis. Intensive Care Med. 2006 Aug;32(8):1115-24. doi: 10.1007/s00134-006-0217-3. Epub 2006 Jun 17.
Results Reference
result
PubMed Identifier
15774056
Citation
Granja C, Lopes A, Moreira S, Dias C, Costa-Pereira A, Carneiro A; JMIP Study Group. Patients' recollections of experiences in the intensive care unit may affect their quality of life. Crit Care. 2005 Apr;9(2):R96-109. doi: 10.1186/cc3026. Epub 2005 Jan 31.
Results Reference
result
PubMed Identifier
22318635
Citation
McKinley S, Aitken LM, Alison JA, King M, Leslie G, Burmeister E, Elliott D. Sleep and other factors associated with mental health and psychological distress after intensive care for critical illness. Intensive Care Med. 2012 Apr;38(4):627-33. doi: 10.1007/s00134-012-2477-4. Epub 2012 Feb 9.
Results Reference
result
PubMed Identifier
12847391
Citation
Schelling G, Richter M, Roozendaal B, Rothenhausler HB, Krauseneck T, Stoll C, Nollert G, Schmidt M, Kapfhammer HP. Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery. Crit Care Med. 2003 Jul;31(7):1971-80. doi: 10.1097/01.CCM.0000069512.10544.40.
Results Reference
result
PubMed Identifier
23438256
Citation
Bienvenu OJ, Gellar J, Althouse BM, Colantuoni E, Sricharoenchai T, Mendez-Tellez PA, Shanholtz C, Dennison CR, Pronovost PJ, Needham DM. Post-traumatic stress disorder symptoms after acute lung injury: a 2-year prospective longitudinal study. Psychol Med. 2013 Dec;43(12):2657-71. doi: 10.1017/S0033291713000214. Epub 2013 Feb 26.
Results Reference
result
PubMed Identifier
18774425
Citation
Davydow DS, Gifford JM, Desai SV, Needham DM, Bienvenu OJ. Posttraumatic stress disorder in general intensive care unit survivors: a systematic review. Gen Hosp Psychiatry. 2008 Sep-Oct;30(5):421-34. doi: 10.1016/j.genhosppsych.2008.05.006. Epub 2008 Jul 30.
Results Reference
result
PubMed Identifier
11373423
Citation
Jones C, Griffiths RD, Humphris G, Skirrow PM. Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med. 2001 Mar;29(3):573-80. doi: 10.1097/00003246-200103000-00019.
Results Reference
result
PubMed Identifier
9559601
Citation
Schelling G, Stoll C, Haller M, Briegel J, Manert W, Hummel T, Lenhart A, Heyduck M, Polasek J, Meier M, Preuss U, Bullinger M, Schuffel W, Peter K. Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med. 1998 Apr;26(4):651-9. doi: 10.1097/00003246-199804000-00011.
Results Reference
result
PubMed Identifier
17316451
Citation
Jackson JC, Hart RP, Gordon SM, Hopkins RO, Girard TD, Ely EW. Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: assessing the magnitude of the problem. Crit Care. 2007;11(1):R27. doi: 10.1186/cc5707.
Results Reference
result
PubMed Identifier
25654178
Citation
Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015 May;43(5):1121-9. doi: 10.1097/CCM.0000000000000882.
Results Reference
result
PubMed Identifier
26735627
Citation
Patel MB, Jackson JC, Morandi A, Girard TD, Hughes CG, Thompson JL, Kiehl AL, Elstad MR, Wasserstein ML, Goodman RB, Beckham JC, Chandrasekhar R, Dittus RS, Ely EW, Pandharipande PP. Incidence and Risk Factors for Intensive Care Unit-related Post-traumatic Stress Disorder in Veterans and Civilians. Am J Respir Crit Care Med. 2016 Jun 15;193(12):1373-81. doi: 10.1164/rccm.201506-1158OC.
Results Reference
result
PubMed Identifier
22584757
Citation
Garrouste-Orgeas M, Coquet I, Perier A, Timsit JF, Pochard F, Lancrin F, Philippart F, Vesin A, Bruel C, Blel Y, Angeli S, Cousin N, Carlet J, Misset B. Impact of an intensive care unit diary on psychological distress in patients and relatives*. Crit Care Med. 2012 Jul;40(7):2033-40. doi: 10.1097/CCM.0b013e31824e1b43.
Results Reference
result
PubMed Identifier
19837741
Citation
Cuthbertson BH, Rattray J, Campbell MK, Gager M, Roughton S, Smith A, Hull A, Breeman S, Norrie J, Jenkinson D, Hernandez R, Johnston M, Wilson E, Waldmann C; PRaCTICaL study group. The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ. 2009 Oct 16;339:b3723. doi: 10.1136/bmj.b3723. Erratum In: BMJ. 2009;339. doi: 10.1136/bmj.b4445.
Results Reference
result
PubMed Identifier
2642400
Citation
Bergbom-Engberg I, Haljamae H. Patient experiences during respirator treatment--reason for intermittent positive-pressure ventilation treatment and patient awareness in the intensive care unit. Crit Care Med. 1989 Jan;17(1):22-5. doi: 10.1097/00003246-198901000-00006.
Results Reference
result
PubMed Identifier
11246306
Citation
Nelson JE, Meier DE, Oei EJ, Nierman DM, Senzel RS, Manfredi PL, Davis SM, Morrison RS. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med. 2001 Feb;29(2):277-82. doi: 10.1097/00003246-200102000-00010.
Results Reference
result
PubMed Identifier
10660851
Citation
Novaes MA, Knobel E, Bork AM, Pavao OF, Nogueira-Martins LA, Ferraz MB. Stressors in ICU: perception of the patient, relatives and health care team. Intensive Care Med. 1999 Dec;25(12):1421-6. doi: 10.1007/s001340051091.
Results Reference
result
PubMed Identifier
11940739
Citation
Rotondi AJ, Chelluri L, Sirio C, Mendelsohn A, Schulz R, Belle S, Im K, Donahoe M, Pinsky MR. Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med. 2002 Apr;30(4):746-52. doi: 10.1097/00003246-200204000-00004.
Results Reference
result
PubMed Identifier
10470711
Citation
Simini B. Patients' perceptions of intensive care. Lancet. 1999 Aug 14;354(9178):571-2. doi: 10.1016/S0140-6736(99)02728-2.
Results Reference
result
PubMed Identifier
7894560
Citation
Soehren P. Stressors perceived by cardiac surgical patients in the intensive care unit. Am J Crit Care. 1995 Jan;4(1):71-6.
Results Reference
result
PubMed Identifier
20502874
Citation
Kalfon P, Mimoz O, Auquier P, Loundou A, Gauzit R, Lepape A, Laurens J, Garrigues B, Pottecher T, Malledant Y. Development and validation of a questionnaire for quantitative assessment of perceived discomforts in critically ill patients. Intensive Care Med. 2010 Oct;36(10):1751-1758. doi: 10.1007/s00134-010-1902-9. Epub 2010 May 26.
Results Reference
result
PubMed Identifier
29181557
Citation
Kalfon P, Baumstarck K, Estagnasie P, Geantot MA, Berric A, Simon G, Floccard B, Signouret T, Boucekine M, Fromentin M, Nyunga M, Sossou A, Venot M, Robert R, Follin A, Audibert J, Renault A, Garrouste-Orgeas M, Collange O, Levrat Q, Villard I, Thevenin D, Pottecher J, Patrigeon RG, Revel N, Vigne C, Azoulay E, Mimoz O, Auquier P; IPREA Study group. A tailored multicomponent program to reduce discomfort in critically ill patients: a cluster-randomized controlled trial. Intensive Care Med. 2017 Dec;43(12):1829-1840. doi: 10.1007/s00134-017-4991-x. Epub 2017 Nov 27.
Results Reference
result
PubMed Identifier
30701294
Citation
Kalfon P, Alessandrini M, Boucekine M, Renoult S, Geantot MA, Deparis-Dusautois S, Berric A, Collange O, Floccard B, Mimoz O, Julien A, Robert R, Audibert J, Renault A, Follin A, Thevenin D, Revel N, Venot M, Patrigeon RG, Signouret T, Fromentin M, Sharshar T, Vigne C, Pottecher J, Levrat Q, Sossou A, Garrouste-Orgeas M, Quenot JP, Boulle C, Azoulay E, Baumstarck K, Auquier P; IPREA-AQVAR Study Group. Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year. Intensive Care Med. 2019 Feb;45(2):223-235. doi: 10.1007/s00134-018-05511-y. Epub 2019 Jan 30.
Results Reference
result
PubMed Identifier
14705607
Citation
Creamer M, Bell R, Failla S. Psychometric properties of the Impact of Event Scale - Revised. Behav Res Ther. 2003 Dec;41(12):1489-96. doi: 10.1016/j.brat.2003.07.010.
Results Reference
result
PubMed Identifier
26606250
Citation
Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25.
Results Reference
result
PubMed Identifier
15797699
Citation
Birmes P, Brunet A, Benoit M, Defer S, Hatton L, Sztulman H, Schmitt L. Validation of the Peritraumatic Dissociative Experiences Questionnaire self-report version in two samples of French-speaking individuals exposed to trauma. Eur Psychiatry. 2005 Mar;20(2):145-51. doi: 10.1016/j.eurpsy.2004.06.033.
Results Reference
result
PubMed Identifier
15754668
Citation
Jehel L, Brunet A, Paterniti S, Guelfi JD. [Validation of the Peritraumatic Distress Inventory's French translation]. Can J Psychiatry. 2005 Jan;50(1):67-71. doi: 10.1177/070674370505000112. French.
Results Reference
result
PubMed Identifier
15486169
Citation
Gray MJ, Litz BT, Hsu JL, Lombardo TW. Psychometric properties of the life events checklist. Assessment. 2004 Dec;11(4):330-41. doi: 10.1177/1073191104269954.
Results Reference
result
PubMed Identifier
10887767
Citation
Kubany ES, Haynes SN, Leisen MB, Owens JA, Kaplan AS, Watson SB, Burns K. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess. 2000 Jun;12(2):210-24. doi: 10.1037//1040-3590.12.2.210.
Results Reference
result
PubMed Identifier
8037246
Citation
Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994 Aug;151(8):1132-6. doi: 10.1176/ajp.151.8.1132.
Results Reference
result
PubMed Identifier
6880820
Citation
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Results Reference
result
PubMed Identifier
20096515
Citation
Baumann C, Erpelding ML, Regat S, Collin JF, Briancon S. The WHOQOL-BREF questionnaire: French adult population norms for the physical health, psychological health and social relationship dimensions. Rev Epidemiol Sante Publique. 2010 Feb;58(1):33-9. doi: 10.1016/j.respe.2009.10.009. Epub 2010 Jan 21.
Results Reference
result

Learn more about this trial

Reducing Post-traumatic Stress Disorder After ICU Discharge With the IPREA3 Program

We'll reach out to this number within 24 hrs